Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian P Halcox

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Circulation|July 7, 2011
Letter by Halcox regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction"Julian P Halcox
The New England Journal of Medicine|March 19, 2010
Niacin compared with ezetimibeAlistair C Lindsay, Julian P Halcox
Heart (British Cardiac Society)|March 19, 2014
Lipid-lowering therapy and mortality post-MI: is it just about the LDL?Julian P Halcox, Craig J Currie
Cardiovascular Research|December 5, 2006
Stressing the obvious? Cell stress and cell stress proteins in cardiovascular diseaseAlireza Shamaei-Tousi, Julian P Halcox, Brian Henderson
Circulation|March 14, 2007
Endothelial function and dysfunction: testing and clinical relevanceJohn E Deanfield, Julian P Halcox, Ton J Rabelink
European Journal of Preventive Cardiology|October 5, 2013
Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithmJulian P Halcox, Florence Tubach, Ogün Sazova, et al.
Plos One|September 5, 2018
A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular diseaseChristian A Bannister, Julian P Halcox, Craig J Currie, et al.
Brain, Behavior, and Immunity|October 30, 2016
Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease?Elizabeth A Ellins, D Aled Rees, John E Deanfield, et al.
Open Heart|December 20, 2018
Risk classification in primary prevention of CVD according to QRISK2 and JBS3 'heart age', and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA studyIeuan Johns, Konstantinos E Moschonas, Jesús Medina, et al.
Atherosclerosis|April 22, 2021
Acute effect of a single session of lipoprotein apheresis on central haemodynamics in patients with familial hypercholesterolaemiaElizabeth A Ellins, Suzanne Watkins, D Aled Rees, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Circulation|July 7, 2011
Letter by Halcox regarding article, "OMEGA, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction"Julian P Halcox
The New England Journal of Medicine|March 19, 2010
Niacin compared with ezetimibeAlistair C Lindsay, Julian P Halcox
Heart (British Cardiac Society)|March 19, 2014
Lipid-lowering therapy and mortality post-MI: is it just about the LDL?Julian P Halcox, Craig J Currie
Cardiovascular Research|December 5, 2006
Stressing the obvious? Cell stress and cell stress proteins in cardiovascular diseaseAlireza Shamaei-Tousi, Julian P Halcox, Brian Henderson
Circulation|March 14, 2007
Endothelial function and dysfunction: testing and clinical relevanceJohn E Deanfield, Julian P Halcox, Ton J Rabelink
European Journal of Preventive Cardiology|October 5, 2013
Reclassification of European patients' cardiovascular risk using the updated Systematic Coronary Risk Evaluation algorithmJulian P Halcox, Florence Tubach, Ogün Sazova, et al.
Plos One|September 5, 2018
A genetic programming approach to development of clinical prediction models: A case study in symptomatic cardiovascular diseaseChristian A Bannister, Julian P Halcox, Craig J Currie, et al.
Brain, Behavior, and Immunity|October 30, 2016
Increased fibrinogen responses to psychophysiological stress predict future endothelial dysfunction implications for cardiovascular disease?Elizabeth A Ellins, D Aled Rees, John E Deanfield, et al.
Open Heart|December 20, 2018
Risk classification in primary prevention of CVD according to QRISK2 and JBS3 'heart age', and prevalence of elevated high-sensitivity C reactive protein in the UK cohort of the EURIKA studyIeuan Johns, Konstantinos E Moschonas, Jesús Medina, et al.
Atherosclerosis|April 22, 2021
Acute effect of a single session of lipoprotein apheresis on central haemodynamics in patients with familial hypercholesterolaemiaElizabeth A Ellins, Suzanne Watkins, D Aled Rees, et al.
Pageof 6